Description
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
Affected products
| Vendor | Product | Affected | Fixed |
|---|---|---|---|
| DEXMA | DexGate | 20130114 | — |
Advisories 1
- ICSA-23-271-02 DEXMA DexGate CISA ICS & IT advisories · Sep 26, 2023